Top Markets
Coin of the day
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Rang in Aktien #33732
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Aktienkurs
$4.58
Zuletzt synchronisiert: 2025-05-09
Marktkapitalisierung
$6.98M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel NeuroMetrix, Inc. (NURO)

Kategorie

Gewinn für NeuroMetrix, Inc. (NURO)
Gewinn im Dec 2024 TTM: $-7.81M
Laut den aktuellen Finanzberichten von NeuroMetrix, Inc. betragen die aktuellen Gewinne des Unternehmens $-7.81M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $-6.53M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $-4.42M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von NeuroMetrix, Inc. von 2001 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $-7.81M 0.00%
2024 $-7.81M 19.55%
2023 $-6.53M 47.84%
2022 $-4.42M 93.58%
2021 $-2.28M 9.05%
2020 $-2.09M -44.55%
2019 $-3.77M -16,083.96%
2018 $23.61K -100.18%
2017 $-12.86M -13.77%
2016 $-14.91M 62.32%
2015 $-9.19M 18.30%
2014 $-7.77M -3.15%
2013 $-8.02M -19.87%
2012 $-10.01M 0.26%
2011 $-9.98M -41.33%
2010 $-17.01M -99.86%
2009 $-11.92B 56,302.52%
2008 $-21.13M 152.19%
2007 $-8.38M -287.82%
2006 $4.46M 358.34%
2005 $973.26K -100.01%
2004 $-13.51B 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
2001 0.00 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$7.51B -96,320.18%
US
$5.15B -66,048.81%
US
$5.56B -71,365.19%
IE
$3.86B -49,561.60%
US
$1.42B -18,260.26%
US